CAS RN: 401566-79-8
1-(3-Methyl-1-phenyl-5-pyrazolyl)piperazine
Product Availability
Choose a grade to view its available package options.
1 package records1 with current stock1 grade group
| Batch No. | Package | Availability | Warehouse | Lead Time | Inquiry |
| Batchno.20260613 |
50mg / 250mg / 1g / 5g / 25g / 100g |
Confirm by inquiry |
Shanghai | 5-7 business days | Inquiry |
GET A QUOTE
Packaging options, recorded purity, stock quantity and ship-from location below are generated from the current factory data table for this CAS.
- Pack sizes on record: 0.25g, 1g, 5g, 10g, 25g, 100g
- Available purity: ≥97%
- Inventory rows with stock: 6
- Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 401566-79-8
| Pack Size |
Recorded Purity |
Available Qty |
Ship From |
Inquiry |
| 0.25g |
≥97% |
5
In Stock
|
Shanghai |
Inquiry |
| 1g |
≥97% |
5
In Stock
|
Shanghai |
Inquiry |
| 5g |
≥97% |
5
In Stock
|
Beijing |
Inquiry |
| 10g |
≥97% |
5
In Stock
|
Shanghai |
Inquiry |
| 25g |
≥97% |
5
In Stock
|
Shanghai |
Inquiry |
| 100g |
≥97% |
5
In Stock
|
Hong Kong |
Inquiry |
401566-79-8 / 1-(5-methyl-2-phenylpyrazol-3-yl)piperazine
Standard CAS: 401566-79-8
Multi CAS: No
Basic Information
CAS
401566-79-8
Multi CAS
No
Molecular Formula
C14H18N4
Molecular Weight
242.320000
Exact Mass
242.153147
InChI
InChI=1S/C14H18N4/c1-12-11-14(17-9-7-15-8-10-17)18(16-12)13-5-3-2-4-6-13/h2-6,11,15H,7-10H2,1H3
InChIKey
FBCUUXMVVOANMV-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
18
Aromatic heavy atom count
11
Fraction Csp3
0.36
Rotatable bonds
2
H-bond acceptors
4
H-bond donors
1
Molar refractivity
73.38
TPSA
33.09
LogP / Solubility
WLOGP
1.59
MLOGP
1.4
XLogP3
2.1
Consensus LogP
1.7
Log S (ESOL)
-2.66
Class (ESOL)
Moderately soluble
Log S (Ali)
-2.7
Class (Ali)
Moderately soluble
Log S (SILICOS-IT)
-2.8
Class (SILICOS-IT)
Moderately soluble
ADME
GI absorption
High
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
Yes
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-3.07
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Leadlikeness
No
Synthetic Accessibility
1.5